9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Fluidx Medical Technology, Inc.
M.D. Anderson Cancer Center
University of Southern California
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
Tempus AI
Cedars-Sinai Medical Center
Stanford University
Taproot Health
National Cancer Institute (NCI)
Bayer
Celgene
InSightec
InSightec
OPKO Health, Inc.
InSightec
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Novartis
Centre Hospitalier Universitaire de Besancon
InSightec
Stanford University
University of South Florida
AstraZeneca
InSightec
The University of Texas Health Science Center at San Antonio
Bayer
Mannkind Corporation